
Sinopharm Group
(OTC) SHTDY
Sinopharm Group Financials at a Glance
Market Cap
$2.89B
Revenue (TTM)
CN¥1.15T
Net Income (TTM)
CN¥14.13B
EPS (TTM)
$1.60
P/E Ratio
6.76
Dividend
$0.47
Beta (Volatility)
0.34 (Low)
Dividend
$0.47
Beta (Volatility)
0.34 (Low)
Price
$10.78
Volume
43,640
Open
$10.79
Price
$10.78
Volume
43,640
Open
$10.79
Previous Close
$10.78
Daily Range
$10.77 - $10.81
52-Week Range
$10.57 - $14.87
Estimated Earnings Date
Apr 23, 2026
Dividend
$0.47
Beta (Volatility)
0.34 (Low)
Price
$10.78
Volume
43,640
Open
$10.79
Previous Close
$10.78
Daily Range
$10.77 - $10.81
52-Week Range
$10.57 - $14.87
Estimated Earnings Date
Apr 23, 2026
SHTDY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sinopharm Group
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
94,910
Website
ir.sinopharmgroup.com.cnHeadquarters
Shanghai, 200023, CN
SHTDY Financials
Key Financial Metrics (TTM)
Gross Margin
7%
Operating Margin
3%
Net Income Margin
1%
Return on Equity
9%
Return on Capital
11%
Return on Assets
2%
Earnings Yield
14.79%
Dividend Yield
4.36%
Payout Ratio
59.18%
Stock Overview
Market Cap
$2.89B
Shares Outstanding
268.36M
Volume
43.64K
Avg. Volume
86.27K
Financials (TTM)
Gross Profit
CN¥40.09B
Operating Income
CN¥16.21B
EBITDA
CN¥20.38B
Operating Cash Flow
CN¥14.14B
Capital Expenditure
-CN¥1.62B
Free Cash Flow
CN¥12.52B
Cash & ST Invst.
CN¥61.60B
Total Debt
CN¥108.65B
Sinopharm Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CN¥283.78B
-4.0%
Gross Profit
CN¥20.70B
-18.0%
Gross Margin
7.29%
N/A
Market Cap
$2.89B
N/A
Market Cap/Employee
$26.73K
N/A
Employees
108,217
N/A
Net Income
CN¥3.62B
-26.8%
EBITDA
CN¥11.06B
-18.0%
Quarterly Fundamentals
Total Cash
CN¥61.60B
-3.5%
Total Debt
CN¥108.65B
+47.3%
Accounts Receivable
CN¥206.78B
+11.3%
Inventory
CN¥63.38B
+5.6%
Long Term Debt
CN¥6.14B
-64.4%
Short Term Debt
CN¥102.51B
+81.3%
Return on Assets
1.83%
N/A
Return on Invested Capital
10.95%
N/A
Free Cash Flow
CN¥47.30B
-20.2%
Operating Cash Flow
CN¥48.25B
-20.2%